An interventional study of supervised training and daily walking in Knee Osteoarthritis and Oxidative Stress, sponsored by Mariette Boshuis. Recruiting at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-29.
Sponsored by Mariette Boshuis · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 32 studies in Osteoarthritis, Knee with a site in Netherlands — 9 open to participants now, 11 under way, 1 of them phase 3. Osteoarthritis, Knee · Netherlands.
Among the 32 studies in Osteoarthritis, Knee with a site in Netherlands, this one is the 17th largest by planned enrollment of the 21 interventional ones that give a count, is one of 4 that started in 2025, is one of 14 with no phase, reaches primary completion later than 6 of the 10 other live ones, and was the 31st registered.
3,295 studies on the registry are indexed under Osteoarthritis, Knee; 624 are open to participants now.
Browse Osteoarthritis, Knee studies →9 of the 32 studies in Osteoarthritis, Knee with a site in Netherlands are open now. Recruiting first, the newest first:
UMC Utrecht · Sites in Netherlands
Ages 45+
Next Biomedical Co., Ltd. · Sites in Netherlands, Belgium
Ages 50+
Sint Maartenskliniek · Sites in Netherlands
Ages 45–80
Dijklander Ziekenhuis · Sites in Netherlands
Ages 18–100
Ziekenhuis Oost-Limburg · Sites in Netherlands, Belgium
Ages 18+
A study can be open while its sites in Netherlands have not opened yet or have stopped. Only those recruiting at a site in Netherlands →
Of the 383 Osteoarthritis, Knee studies recruiting now, 177 (46%) set no upper age limit and 113 (30%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
32 studies; the count open now beside each. This study's row is marked.
First in 2001; this study’s year is marked. 4 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 20 is below the median of 68 across 2,717 interventional studies indexed under Osteoarthritis, Knee.
Median enrollment 72 across the 21 interventional studies, 100 across the 11 observational. Of the 18 that completed or were terminated, 7 (39%) have results posted.
This tab as a report to print or save as PDF → With an account.
13 of 32 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Mariette Boshuis as lead sponsor.
Mariette Boshuis has 1 study filed under Osteoarthritis, Knee — fewer than ten, so there is no comparison to draw.
4 of the studies in Osteoarthritis, Knee with a site in Netherlands that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06127719Dijklander ZiekenhuisThe Effects of Surgical Wait Time for Knee Arthroplasty Quality of Life in Patients Awaiting Knee Arthroplasty | 2026-12 |
| NCT07423858UMC UtrechtPredicting The Right Advice at The Right Time in Patients With Hip and Knee OsteoArthritis: the e-cOAch Cross-over. | 2027-02 |
| NCT06930677Next Biomedical Co., Ltd.Study in Patients With Knee Osteoarthritis Treated by Embolization Using NBGM200 | 2027-02 |
| NCT07845838Mariette BoshuisThe Effect of Training on Oxidative Stress in Patients With kneeOA. | 2027-06-01 |
Add all 4 to your calendar (.ics) → With an account.
Among the 32 studies in Osteoarthritis, Knee with a site in Netherlands, from their registry updates:
This tab as a report to print or save as PDF → With an account.
A six week patient study that intends to prove that training helps improve the life of people with osteoatritis of the knee.
It looks at pain and function in daily life and markers in the blood that show stress at a cell level.
In this study you will be part of a group one that receives 6 weeks of training (2 sessions per week) or you are part of group two that will exercise by walking 6000 steps per day.
To investigate the effect of the training and walking, there will be an first screening of your capillary blood (by use of a few drops of blood from your finger), and you will be asked to fill in some questionnaires about your symptoms, that will include a painscore and a questionair on your specific complaints. These test will be retaken at the end of your 6 weeks of training.
The study is focussed to benefit you by strengthening the muscles around your knee and improving your overall fitness.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
the patient will recieve 6 weeks of 2 supevised trainings per week as an outpatient
Other: supervised training
the patient will walk 6000 steps per day for the duration of 6 weeks
Other: daily walking
supervised training by a trained physical therapist, focussed on strength and overall fitness
walking 6000 steps per day unsupervised
NRPS Pain score
numeric pain rating scale
Time frame: 6 weeks
PSPF
Patient Specific Functional Scale
Time frame: 6 weeks
oxidative stress bloodmarkers
d-Roms fast test
Time frame: 6 weeks
Plan to share: No
Started May 2025 (actual). Primary completion is estimated for Jun 2027, 24 months after the start.
Of 1,111 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 24 months is above that.
Counting every sponsor, half of 1,251 studies reached it within 18 months; a quarter within 8 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.